Medicenna Therapeutics (NASDAQ:MDNA) Stock Suddenly Gains Momentum On High Volume

January 20, 2022

This morning man investors are possibly going to focus on the clinical stage immuno-oncology firm Medicenna Therapeutics (NASDAQ:MDNA), considering the fact that its stock had moved strongly on Wednesday. Trading Data On Wednesday, MDNA stock moved up 7.70% to $1.54 with more than 94k shares, compared to its average volume of 204K shares. The stock has moved within a range of $1.4700 – 1.5500 after opening trade at $1.47. Medicenna…

Read More >>